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The key events that lead to organismic senescence 
appear to occur in cells that have been genetically pro-
grammed to arrest their own proliferation. After arrest, 
a variety of subcellular events occur, among the more 
important of which are the accumulation of waste prod-
uct pigments, an increase in the fraction of inactive 
enzymes, and (probably of central importance) the loss 
of key genes, specifically those that code for rRNA. An 
understanding of the senescence of the epidermis and 
dermis would almost certainly provide answers to re-
lated problems in those organ systems whose sudden or 
slow failure leads to individual death. 
At this point in time, 80% through the 20th century, we still 
are unable to predict with any degree of certainty the extent to 
which the aging process will be retarded or arrested for future 
generations of humans. The reason is quite simple: we lack 
essential basic information on the origins and mechanisms of 
age-related cell dysfunctions that gradually lead to a logarith-
mically increasing predisposition to disease and death. This 
lack is partially due to the fact that one must understand the 
essential features of any complex machine before one can 
anticipate the ways in which it will deteriorate; we are now, I 
suspect, on the verge of understanding some very intricate 
aspects of molecular biology (particularly DNA, and the factors 
that control its selective expression during development). The 
deficit in our understanding of the mechanisms of senescence is 
also due to the fact that the biology of aging had a much 
delayed pubescence and is only now approaching sexual matu-
rity as a member of the family that includes cell and chemical 
biology. As the number of highly capable individuals who find 
this area challenging scientifically (and fundable federally) 
grows, the relationship between the explosive growth of infor-
mation on genes, their structures, their regulation, and their 
later life manifestations of genetic qualities (aging) will mature 
into at least a marriage of convenience. 
Possibly a real impediment to rapid advances in our under-
standing of the aging phenomenon in humans is the very speed 
at which new, detailed information is being generated and 
published. Too much information of uncertain relevance to a 
given puzzle is almost as frustrating as too little information of 
clear relevance. Many modern biological gerontologists must 
decide between pursuing currently unpopular concepts (which 
are inherently difficult to fund), pursuing fundable descriptive 
studies that are certain to yield publishable results, or running 
aground in a middle channel on an uncertain sea of undigested 
or undigestable groups of new facts. 
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Nevertheless, as one not easily moved to pessimism, I believe 
that a reasonably comprehensive grasp of the problem as well 
as the degree to which it can be moderated in the future should 
be in our hands by the end of this century and that Benjamin 
Franklin's projection in a letter to Joseph Priestly in 1780 is, in 
fact, a quite conservative statement in the light of the state of 
modern biology. He said: "It is impossible to imagine the height 
to which may be carried in a thousand years, the power of man 
over matter .... Agriculture may diminish its labor and double 
(!!) its produce; all diseases may by sure means be prevented, 
not excepting that of old age, and our lives lengthened at 
pleasure even beyond the antediluvian standard .... " [1]. 
2 
In the following pages, I shall sketch in some of the reasons 
underlying this optimism and detail what seem to be particu-
larly promising leads for future basic fltudies, including some 
that concern the most visible parts of the body-the skin and 
its appendages. I would like to thank my friend Bill Montagna 
for making it possible for me to attend and address this meeting. 
I regret that I have not yet been able to contribute so substan-
tially to my field as he has to his. 
FUNDAMENTALS OF BIOLOGICAL AGING 
The 1st generalization (largely documented by the extensive 
studies of Nathan Shock and co-workers) to be kept in mind is 
that most bodily functions decrease by about 1% per year after 
maturity has been reached [2,3], whereas the probability of 
demise increases geometrically with adv.ancing age (as fIrst 
noted by Benjamin Gompertz in the early 19th century) [4]. 
The doubling time for human mortality is about 7 yr in modern 
societies, and age-specific death rates increase from about 1 in 
8,000 per year (in the very young) to about 1 in 5 per year in 
the very aged. 
The 2nd generalization is that the harmful effects of aging 
occur almost exclusively in cells that have been programmed, 
during development, to cease undergoing mitosis [5]. In the 
case of muscle, this arrest of mitosis is probably related to the 
manner of muscle formation (fusion of myoblasts) ; in the case 
of the central nervous system continued mitosis after birth 
would tend to prevent the fIxation of memory in a geometrically 
unstable structure and to interfere with the retrieval of infor-
mation from this key organ. Continued restructuring of major ' 
blood vessels would also have major, though perhaps not insur-
mountable, side effects. On the one hand (with respect to tissues 
whose cells are undergoing mitosis), few persons succumb to 
damage to replenishing cell types, including epidermis, gut 
lining, and erythrocytes; on the other hand, many succumb to 
decreased performances by nonreplenishing components of the 
central nervous system, by nonreplenishing parts of the immune 
system, and by the endocrine system. 
The 3rd generalization is that the longevities of different 
species are genetically determined. A 100-yr-old man is a rarity; 
a 100-yr-old mouse is an absurdity; a 1,000-yr-old tree is not 
uncommon; the oldest of living things (bristle cone pines) were 
seedlings when the Egyptians settled along the Nile. 
The 4th generalization is that mobility requires a suitably 
effective movement-controlling system (the central nervous 
system) and that longevity increases as the mental ability 
July 1973 
increases (as measured by the ratio of brain mass to body mass). 
From this idea it also follows that the longevity of higher 
mammals has gradually increased during evolution and has 
been particularly rapid in prehumanoids and humanoids. Some 
have interpreted this to mean that relatively few mutations are 
required to produce substantial increases in longevity [6,7]; 
others have maintained that prehumanoid and early human 
societies were so structured that they favored the rapid fixation 
of beneficial genotypes in small populations, through polygamy, 
for example [8). Rates of advantageous mutation fixation may 
be increased by 1 or more orders of magnitude if the degree of 
polygamy and the degree of phenotypic differences between 
competing males that determine who will be the "dominant" 
patriarch of the next generation(s) are sufficiently increased. 
The 5th generalization is that aging is primarily a delayed 
deleterious pleiotropic [9] side effect of genes that confer ad-
vantages in other aspects of function or structure. For example, 
as pointed out by Bidder [10], there is an optimum size for each 
species of land animal that necessitates the inclusion in the 
genes of instructions to arrest mitosis of key kinds of body cells 
after maturity has been reached. Similar pleiotropic advantages 
of mitotic arrest are implicit in the earlier statements regarding 
continual replacement of cells in the central nervous system. 
The 6th and final generalization is that although every con-
ceivable kind of maladaptive change occurs in nonreplenishing 
components of living systems at some rate (and more slowly in 
replenishing components), a relatively small group of harmful 
changes dominate (determine) the rate of aging. At the orga-
nismic level, failures of communication systems such as the 
central nervous and endocrine systems, together with dysfunc-
tions of the immune system and of the cardiovascular system, 
dominate the human aging landscape. At the cellular and 
subcellular levels, changes in membrane (including membrane-
bound receptor) properties, accumulation of age pigments, dys-
function of translational machinery, and, perhaps most impor-
tant of all, damage to DNA itself seem to be the key events 
that limit the functional life span of individual postmitotic cells. 
(See reference 11 for documentation of the above generaliza-
tions.) 
MOLECULAR EVENTS AND AGING AT THE 
CELLULAR LEVEL 
Relationship between Development and Aging 
For many years the truism that aging begins with conception 
was fashionable among many otherwise critical biologists [12-
14). It would be absurd to accept this dictum without question 
for the very simple reason that we do not know enough about 
either of the processes to state categorically that it is true. A 
safer statement is that (in humans) aging, as measured by 
decreased survival ability, begins at about the time that mor-
tality is at itS nadir and that vigor, except probably mental 
vigor, reaches its zenith. But the safest statement that can be 
made is that developmental processes (during 1 or more phases 
of development) set the stage, as it were, for the later expression 
of the deteriorative changes that we term aging. The safety in 
this statement lies in its essential lack of content. 
Here are 2 trivial examples. First, the number of sets of teeth 
the normal human erupts is 2. This limitation is most certainly 
genetically/ developmentally determined, and as wear and tear, 
caries, and periodontal and gingival disease erode the dental 
surfaces and roots, teeth eventually are lost. Second, many of 
the cells and constituents of the dermis are "permanent" struc-
tures. As ultraviolet damage to these elements occurs, the skin 
changes its texture and assumes an aged appearance. 
But the philosopher-scientists who first proposed that devel-
opment causes aging were not referring to areas such as the 
skin and teeth. It was toward the deeper, and with apologies to 
the interests of those attending this conference, more central 
organ systems that the dictum was directed. What they meant, 
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I assume, is that "vital" organs such as the heart, brain, mus-
culature, and endocrine and immune systems are programmed 
by "developmental genes" to undergo inevitable deterioration 
and that such deterioration commences even before birth. It is 
my conviction that Williams [9] was essentially correct in his 
statement that aging is (merely?) a late pleiotropic side effect 
of development. The argument is that at least some develop-
mental processes are highly advantageous during early life, but 
have delayed harmful side effects that eventually lead to senes-
cence and death. Possibly at the risk of being simplistic, I am 
suggesting that a single kind of process, namely the arrest of 
mitosis in certain vital body cells, is the basic origin of the 
eventual aging of humans and of other highly evolved forms 
of life. 
If this thesis is valid, the ultimate causes of death are to be 
found in those particular genetic instructions that, when exe-
cuted, lead to a suppression of proliferative ability in so-called 
postmitotic cells. Furthermore, to identify these ultimate causal 
events, one must understand how cell proliferation is selectively 
stimulated and arrested in various body systems, including the 
epidermis. 
Two main sites have been proposed as the "control points" 
for the expression of particular genes or combinations of genes. 
One point is at the sites of transcription, an extension of the 
classical concepts developed by Jacob and Monod [15] for 
adaptive enzyme formation in prokaryotes-namely, in the 
regulation of the transcription of mRNA. The other potential 
control points work at later stages in the synthesis of proteins, 
specifically on the machinery that permits (or fails to permit) 
the synthesis of particular groups of proteins. Both options 
seem viable, although most molecular biologists favor the for-
mer over the latter, even though the complexity of the necessary 
control system is very much greater if one uses a eukaryotic 
operon model as the vector for selective gene expression and 
repression. There is considerable, very persuasive evidence that 
gene activation in a limited variety of cell types is controlled in 
eukaryotes during transcription [16,17). Of particular note are 
the studies on the stimulation of the avian oviduct to produce 
ovalbumin and other materials that later become incorporated 
into a maturing avian ovum. The hormones that stimulate 
secretion of these materials clearly interact with cytoplasmic 
factors, which then interact with clu:omatin so as to favor the 
increased production of the appropriate messages-and the 
appropriate protein syntheses. 
Nevertheless, these "reflex" synthetic responses may well be 
specialized adaptations rather than the lule during develop-
ment. There is an equally tantalizing body of evidence, most 
recently derived from the determination of the specific se-
quences of particular messenger RNA's and genes [18-22], that 
suggests, at least to some workers, that what a cell manufac-
tures is determined by the assortment of code words it is able 
to decode. Table I lists specific messages or genes in which 
certain code words are not used. In many instances, the unfa-
vored words contain the sequence C-G, but this rule is by no 
means immutable. Without belaboring the point or taking a 
dogmatic stand on the issue, I think the concept that codon 
usage modulation is an important part of the developmental 
program in eukaryotes is still highly viable (23). Equally telling 
are some recent experiments, reported by Stacey and Allfrey 
[24], in which the majority of cells present in developing chick 
and duck embryos were unable to produce detectable amounts 
of duck globin peptides even though the message for duck 
globin had been introduced into these ceils through microinjec-
tion techniques. By contrast, HeLa cells were uniformly able to 
translate the injected message in 100% of trials. These fmdings 
mean either (a) that the majority of cells in developing embryos 
cannot translate the injected message or (b) that the message 
is selectively degraded in these cells. These fmdings contradict 
those reported by Gurdon, who has presented evidence that 
cells well along the path of specific differentiation in developing 
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TABLE 1. DNA triplet code numbers and usages in vertebrate genes 
or messages",I, 
Condons RB HB RPGH HCS Oval VLCM 
ITA = LUI 1 3 1 (1) 
TTG = LU2 2 4 
CIT = LU3 1 8 1 (1) 
CTA = LU5 3 1 2 (2) 
ATT = ILl 1 3 2 6 2 
ATC = IL2 5 5 16 1 (1) 
ATA = IL3 3 3 
GTT = VAl 4 2 9 4 
GTA = VA3 5 
TCT = SRI 3 0(1) 2 3 (1) 
TCA = SR3 2 1 10 5 
TCG = SR4 2 4 7 
CCT = PRI 3 5 1 (1) 1 2 
CCC = PR2 5 (1) 2 6 
CCG = PR4 1 1 
ACA = TH3 1 3 4 (3) 
ACG = TH4 2 7 
GCT = ALI 7 7? 7 (3) 7 
GCG = AU 1 2 0 10 
TAC = TY2 2 1 3 4 2 (2) 
TAA = STOP 1 7 
TAG = STOP 1 1 1 
CAT = HSI 4 2 2 2 
CAA = GNI 1 (1) 2 4 1 
AAT = ANI 4 1 2 1 8 • (1) 
TGC = CY2 2 (1) 3 10 1 
TGA = STOP 1 1 
CGT = ARI 2 
CGC = AR2 6 4 
CGA = AR3 • 1 2 
CGG = AR4 1 2 
AGC = SR6 6 (1) 4 2 
AGA = AR5 1 9 1 (3) 
AGG = AR6 3 3 1 3 10 
GGT = GYI 4 4 1 (1) 3 6 (1) 
GGA = GY3 1 3 3 (1) 
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" Only those condons that are not used in at least 1 message or gene 
are listed. The similarities between the 2 sequenced globin messages 
are much more striking than are the resemblances between other 
restricted condonic patterns. This fact suggests that there is consider-
able conservation of these codon usages within this tissue type. 
" The asterisk indicates that the code word is not used at all in this 
message or gene. 
Abbreviations: RB = rabbit f3 chain; HB = human f3 chain; RPGH 
= rat pre growth hormone (numbers in parentheses are not in the final 
product); HCS = human chorioallantoic somatotropin; Oval = oval-
bumin; VLCM = variable light chain mouse (numbers in parentheses 
are present in part of constant chain coding region). 
amphibian embryos are still able to manufacture globin pro-
teins. One possible criticism of the Gurdon experiments is that 
the enormous levels of radioactive histidine in which his embryo 
fragments were incubated favored the exchange-incorporation 
of labeled histidine into preexisting globin chains. There is, of 
course, no doubt that the amphibian oocyte is able to translate 
a plethora of different kinds of messages, but it does not 
necessarily follow that the differentiating descendents of these 
cells retain a "universal" decoding ability. 
On the basis of the above findings and others reported from 
our laboratory at the University of Southern California 
[25-27], I am not yet inclined to dismiss the very real possibility 
that the primary event in development that leads to later 
senescence is the switching off of capacities to translate mes-
sages whose products are required for mitosis-an indirect 
result of the loss of specific isoaccepting species of tRNA or of 
the function of cognate tRNA amino-acylases, more likely the 
latter. 
In summary of this section, the relationship of developmental 
program to later senescence is very likely a pleiotropic side 
effect of the developmental repression of the capacity of certain 
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kinds of cells to undergo mitosis. The repression of this key 
ability leads to senescence of postmitotic cells because of sub-
sequent deteriorative changes that are not completely reparable 
in these cells. Hence the remaining function of these key 
systems slowly declines and eventually leads to senescence. One 
key issue that remains to be resolved is whether this loss of 
synthetic ability is derived from the loss of ability to transcribe 
the necessary mRNAs or, alternatively, to translate such mes-
sages. Possibly there is a mixture of both kinds of processes in 
different systems. (A more 'detailed and critical discussion of 
these issues is presented in references 11 and 28.) 
Some Key Molec;ular Changes in Aging Cells 
In this section, 5 kinds of changes in postmitotic and quasi-
postmitotic cells and tissues will be presented and discussed. 
These are: (1) tissue disorganization, (2) loss of the division 
potential in mitotic cells (clonal senescence), (3) accumulation 
of inactive enzymes, (4) accumulation of large amounts of so-
called age pigment, and (5) evident loss or inactivation of 
certain tandemly duplicated genes, specifically the key sets of 
genes (rDNA) responsible for the synthesis of ribosomal RNA. 
Because some of these topics are covered by other participants, 
they will be mentioned only in passing. 
Tissue Disorganization 
A casual inspection under the microscope of tissues from 
humans of different ages reveals that usually the younger tissue 
sections possess relative uniformity in cell size and regularity in 
cell arrangement; by contrast, sections of older tissues generally 
show a decrease in regularity of spacing, a gradual increase in 
differences in cell size, and greater variability in intracellular 
organelles from cell to cell. Few investigators have determined 
the numbers that correspond to these obvious visual impres-
sions, even though the painstaking work of Tauchi and Sato on 
liver gives some substantiation to this conclusion [29]. Similarly, 
when one measures various physiological functions in tissues 
from individuals of different ages, the rule is that the range of 
remaining function increases as the age increases, as does 
variability in the amount of age pigments, for example, in older 
cardiac tissue. 
Clonal Senescence 
The pioneering work of Hayflick [30,31] has demonstrated 
that fibroblasts under culture conditions gradually lose the 
ability to undergo mitosis. Somewhat less persuasive is the 
observation that the age of a donor is negatively correlated with 
the number of divisions observable under culture conditions 
[32]. One must exercise some caution in accepting this conclu-
sion because: (a) substantial variability exists in the maximum 
number of doublings attainable when samples are taken from 
adjacent skin areas of the same individual and (b) the number 
of cells in a biopsy specimen, as well as the number of divisions 
required to establish a "primary culture" of fibroblasts, may 
respectivel~ decrease and increase in specimens obtained from 
older donors. Regardless of whether fibroblasts from the skin 
of older individuals do in fact have less division potential than 
cells from younger donors, the model very probably is centrally 
important to an understanding of the control of mitosis and 
how this may change as a function of age, in vivo or in vitro. 
Accumulation of Inactive Enzymes 
A fundamental discovery was made by Harriet and David 
Gershon about 8 yr ago [33,34]. They showed that enzymes 
isolated from old tissues (first from nematodes, later from 
mammals) often exhibit a decrease in the rate of catalysis of 
specific reactions per unit of "enzyme," as determined by cross-
reactivity against antibody to the specific enzyme. More re-
cently, extensive studies have revealed that the changes that 
are responsible are quite subtle and probably involve rearrange-
ments in the tertiary structure [35]. The fact that greater 
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amounts of inactive (or not very active) enzymes are present in 
older tissues is believed by some to be due to a slower rate of 
turnover of enzymes in aging tissues, a decrease that permits 
the slow accumulation of greater amounts of inactive enzymes. 
Accumulation of "Age Pigment" 
One of the most universally observed changes during the 
aging of cells (from protozoa such as Tokophrya, through 
nematodes and Drosophila to humans) is the accumulation of 
colored, insoluble, fluorescent residues, particularly in perinu-
clear regions. These were fIrst observed by German pathologists 
a century ago and were termed Alternspigmente or A bnutzung-
spigmente [36). They occur in massive amounts in large neurons 
and may occupy as much as 75% of the extranuclear volume of 
the cell body [37). The aged myocardium contains as much as 
10% of such inclusions [38], and various endocrine cells (e.g., in 
the adrenals and testes) contain massive amounts of these 
materials. Analysis after chemical isolation indicates that they 
are very probably the products of the reaction between reactive 
substances such as malonyl-dialdehyde and amino groups of 
proteins, particularly those present in membranous structures. 
No one has yet demonstrated .whether these inclusion bodies 
are detrimental to cell function, but it is difficult for me to 
imagine that the displacement of 75% of a cell's cytoplasm with 
evidently nonfunctional products would fail to impair the cell's 
optimum response to challenge or its capacity for sustained 
work. 
Loss or Inactivation of Specific Genes 
Possibly the most important change that occurs in aging 
postmitotic cells is the loss of ribosomal deoxyribonucleic acid 
(rDNA), as measured through several different hybridization 
techniques [38- 42). This unanticipated damage to genetic ma-
terial reduces the apparent amount of rDNA per cell by an 
average of about 50% by the time that early senescence has 
been reached (12 yr of age in beagles and 70 yr in humans). 
The effect has been observed in brain, skeletal muscle, and 
cardiac muscle, but not in slowly replenishing tissues such as 
liver and kidney. Comparison of the rDNA loss in human 
somatosensory cortex and the hippocampus indicates there is 
probably only an insignifIcant difference in the rate of loss in 
these 2 parts of the brain. Table II summarizes the data now on 
hand. 
Correlated with this loss of hybridizable rDNA is a loss of 
cytoplasmic rRNA (Nissl bodies) in the cell bodies of large 
neurons, as demonstrated by Mann and Yates [43). There are 
mutant strains of Drosophila, called bobbed mutants, that have 
reduced amounts of this material. Anuclolate mutants of am-
phibia also possess reduced amounts of this genetic material. 
Unpublished work from our laboratory has demonstrated that 
in the former species the more extreme the bobbed character 
is, the shorter is the lifetime. Normal fruit flies live about 28 
days under our culture conditions; the mutant versions live for 
about 22 to 23 days. Unfortunately, no one has yet measured 
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the longevity of amphibia that are defIcient in rDNA, but 
reduction of the level below about 40% of the normal value 
produces nonviable embryos. 
This loss of genetic material (whether through cross-linkage 
of DNA or by physical deletion) would be expected to reduce 
the maximum work rate of cells responding to stresses in those 
cases in which rRNA is rate-limiting in the response. No studies 
on individual cells defIcient in rDNA have yet been carried out. 
The simple fact, of course, that decreased function is correlated 
with a loss of rDNA does not establish a causal relationship 
between these 2 phenomena. This subject appears to be a 
promising area for future research. 
The Skin and Its Appendages as Objects for Basic 
Gerontological Studies 
Possibly because very few persons die of "old skin," and 
many die as a result of the failure of less superfIcial organs, skin 
has, in my opinion, not been adequately used as an object for 
aging research. It is true that skin is the most convenient source 
of biopsy specimens for clonal aging studies. Skin and its 
appendages show obvious age changes, and skin is the fIrst 
datum item we use in appraising an individual's age. Finally, 
skin is embryologically closely related to the most remarkable 
of all biological systems, the central nervous system. Neverthe-
less, some obvious and other not so obvious uses of skin to 
answer key questions on biologic!Jl aging have not been empha-
sized. In the last section of this paper I shall pose some questions 
that, because they are susceptible to experimental attack, may 
furnish insights into what occurs in deeper, more "vital" organ 
systems. 
The 1st question is relevant to clonal aging, as discussed in a 
previous section. We obviously need to know whether the 
marginally signifIcant decrease in division potential of fIbro-
blasts obtained from skin specimens from old individuals re-
flects a decreased number of potentially mitotic cells or mirrors 
changes intrinsic to.the dermal fIbroblasts. To resolve this issue, 
we need to determrne how many fIbroblasts enter mitosis per 
mass unit of biopsy specimen (or more specifIcally, dermis) as 
a function of donor age. The techniques required to answer this 
question seem very straightforward. 
The 2nd question is whether basal cells are capable of indef-
inite numbers of replications. Many years ago, co-workers and 
I conducted studies to test whether basal cells are capable of 
indefInite numbers of divisions or, alternatively, whether the 
population dynamics of basal cells are such that after 1 group 
of stem cells has acted as the source of epidermal cells, other 
"clon'es" repopulate the basal cell layer sequentially. Using 
tritium-labeled sections of human epidermis (from a patient 
with psoriasis), we demonstrated that the migration of cells out 
of the basal cell layer is random (see reference 11). Therefore, 
there is no obvious clocking system that leads to a repopulation 
of the basal cell layer with "young" basal cell clones, unless 
psoriasis itself changes the orderly division regimen of this 
kind of cell in nonpsoriatic areas of the skin. What we need to 
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do is find out, once and for all, whether "normal" epidermis 
behaves like psoriatic epidermis with respect to possible clonal 
senescence. If human volunteers are required, I am willing to 
donate a small expanse of supragluteal epidermis for the nec-
essary labeling studies. 
A 3rd research question concerns the different growth prop-
erties of hair from different sites. The ability to maintain a 
luxuriant growth of hair on the frontal regions of the scalp is 
lost at a fairly young age. The remedy that Orentreich and 
others have developed is to transplant hair follicles to this 
region from regions (e.g., occipital scalp) that have a longer 
inherent growth potential. It is of gerontological interest to 
determine what differentiates an occipital hair follicle from a 
frontal one, essentially because one system shows early aging 
and the other shows a delayed expression of the process. 
A closely related question concerns the fact that the greying 
of hair is nonuniform. Beard hair and side burn hair tend to lose 
their pigmentation much earlier than do hair in the adjacent 
scalp. These hairs are also usually more coarse and curly. I am 
most puzzled by the fact that some beard hair display one kind 
of pigmentation, and others, quite close by, display very differ-
ent pigmentations. One beard (with which I was intimately 
familiar) comprised a mosaic of black, red, blond, brown, and 
white hairs-a truly multiracial pigment display. The question, 
of course, is what random or programmed event causes 2 
adjacent hair follicles to express quite different phenotypes. 
Unless h~ir color is totally different from other genetically 
determined phenotypic expressions, the differences observed 
must reflect differential gene expressions whose effects are 
observable with the unaided human eye. To the degree that 
plucked hair follicles can serve as a source of materials for in 
vitro studies on cell properties, one might well learn much 
about gene activation and repression by studying such a "su-
perficial" index as variegated hair coloration. 
Possibly of more central importance than the questions listed 
above is the issue of the degree to which the underlying dermis 
determines the behavior of overlying hair follicles. More specif-
ically, is there a gradient of some substance, supplied by dermal 
cells, needed for hair growth? Do these cells lose their functions 
at different times in the life cycle? And do dermal cells supply 
some material needed for melanocyte function and for their 
injection of pigment into the adjacent growing hair anlagen? It 
seems likely that a dermal component (perhaps a nonreplenish-
ing one) controls both the growth rate and the pigmentation of 
cells and products derived from the epidermis. It is possible 
that the previously mentioned loss of rDNA (from inductive 
dermal cells ?) determines both the growth rate and the degree 
and kinds of pigmentation that epidermal cells receive from 
adjacent melanocytes. 
The above research areas on aging skin and its appendages 
have relevance, it seems to me, to analogous changes that occur 
in more "vital" organ systems. The advantages of the skin as 
an object for aging research lie both in its accessibility and in 
the possibility that the dermal components closely approximate 
the qualities of organ systems whose failure results in the slow 
onset of senescence and its unpleasant accompaniments. 
SUMMARY 
Although the skin exhibits what appear to be only superficial 
expressions of the aging process, it is likely that it is a most 
appropriate system for studying some of the key processes that 
affect indispensible organ systems such as the central nervous 
system, the cardiovascular system, and hormonal and immu-
nologic responses. 
REFERENCES 
1. Franklin B: Letter to Joseph Priestly, 1780 
2. Shock NW (Ed) : Perspectives in Experimental Gerontology. 
Springfield, Illinois, Charles C Thomas, 1966 
Vol. 73, No. 1 
3. Shock NW: Some physiological aspects of aging in man. Bull NY 
Acad Med 32(2):268-283, 1956 
4. Gompertz B: On the nature of the function expressive of the law of 
human mortality and on a new mode of determining life contin-
gencies. Philos Trans R Soc Lond [A] 115:513-585, 1825 
5. Platt D: Biologie des Alterns. Heidelberg, QueUe & Meyer, 1976 
6. Sacher GA: Maturation and longevity in relation to cranial capacity 
in hominid evolution, Antecedents of Man and After, vol l. 
Edited by R Tuttle. The Hague, Mouton, 1975, pp 417-441 
7. Cutler RG: Evolution of human longevity and the genetic complex-
ity governing aging rate. Proc Nat! Acad Sci USA 72:4664- 4668, 
1975 
8. Strehler B: Polygamy and the evolution of human longevity. Mech 
Aging Dev 9:369-379, 1979 
9. Williams GC: Pleiotropy, natural selection and the evolution of 
senescence. Evolution 11:398-411, 1957 
10. Bidder GP: The mortality of plaice. Nature 115:495, 1925 
11. Strehler BL: Time, Cells and Aging, 2nd edition. New York, Aca-
demic Press, 1977, 456 pp 
12. Minot CS: The problem of age, growth and death. Popular Science 
Monographs 71:481-496, June 1907 
13. Minot CS: The problem of age, growth and death. Popular Science 
Monographs 71:97-120, August 1907 
14. Minot CS: The problem of age, growth and death. Popular Science 
Monographs 71:509-523, December 1907 
15. Jacob F, Monod J: Genetic repression, allosteric inhibition and 
ceUular differentiation, Cytodifferentiation and Macromolecular 
Synthesis. Edited by M Locke. New York, Academic Press, pp 
30-64,1963 
16. Cox RF, Naives ME, Carey NH: Modification of the template 
capacity of chick-oviduct chromatin for form-B RNA polymerase 
by estradiol. Eur J Biochem 32:513-524, 1973 
17. Maurer H , Chalkley G: Some properties of a nuclear bonding site 
of estradiol-17beta. J Mol BioI 27:431:-441, 1967 
18. Efstratiadis A, Kafatos F, Maniatis T: The primary structure of 
rabbit beta-globin mRNA as determined from cloned DNA. Cell 
10:571-585, 1977 
19. McReynolds L, O'Malley BW, Nisbet AD, Fothergill JE, Givol D, 
Fields S, Robertson M, Brownlee GC: Sequence of chick oval-
bumin mRNA. NatUl·e 273:723-728,1978 
20. Baralle F: The nucleotide sequence of human beta globin mRNA. 
Cell 12:1085-1097, 1977 
21. Shine J, Seeburg P, Martial JA, Baxter JD, Goodman HM: Con-
struction and analysis of recombinant DNA for human chorionic 
somatomammotropin. Nature 270:494-499,1977 
22. Seeburg TH, Shine J, Martial JA, Baxter JD, Goodman HM: 
Nucleotide sequence and amplification in bacteria of structural 
gene for rat growth hormone. Nature 270:486-494, 1977 
23. Strehler B, Hirsch G, Gusseck D, Johnson R, Bick M: The codon-
restriction theory of aging and development. J Theor BioI 33: 
429-474, 1971 
24. Stacey D, Allfrey VG: Microinjection studies of duck globin mes-
senger RNA translation in human and avian cells. Cell 9:725-732, 
1976 
25. Hirsch GP, Strehler B: Cross tissue translational capacities. II. 
Relative effectiveness of heterologous synthetases (and other 
supernatant factors) in the translation of hemoglobin message. 
Mech Ageing Dev 2:237-244, 1973 
26. Bick MD, Strehler BL: Leucyl transfer RNA synthetase changes 
during soybean cotyLedon senescence. Proc Nat! Acad Sci USA 
68:224-228, 1971 
27. Streher B, Hendley DD, Hirsch GP: Evidence on a codon restriction 
hypothesis of cellular differentiation: Multiplicity of mammalian 
Jeucyl s-RNA synthetases and tissue-specific deficiency in an 
alanyl sRNA synthetase. Proc Nat! Acad Sci USA 57:1751-1758, 
1967 
28. Andron L, Strehler B: Recent evidence on tRNA and tRNA acry-
lase-mediated cellular control mechanisms: A review. Mech Age-
ing Dev 2:97-116, 1973 
29. Tauchi H, Sa to T: Some micro measuring studies of hepatic cells in 
senility. J Gerontal 17:254-260, 1962 
30. Hayflick L: The limited in vitro lifetime of human diploid cell 
strains. Exp CeU Res 37:614-636, 1965 
31. Hayflick L: Current theories of· biological aging. Fed Proc 34:9-13, 
1975 
32. Martin GM, Sprague CA, Epstein CJ: Replicative life-span of 
cultivated human cells: Effects of donors' age, tissue and geno-
type. Lab Invest 23:86-92, 1970 
33. Gershon H, Gershon D: Detection of inactive enzyme molecules in 
ageing organisms. Nature 227:1214-1217, 1970 
34. Gershon H, Gershon D: Altered enzyme molecules in senescent 
organisms: Mouse muscle aldo]/ISe. Mech Ageing Dev 2:33-41, 
1973 
35. Rothstein M: Aging and the alteration of enzymes. Mech Ageing 
Dev 4:325-338, 1975 
36. Stu bel H: Die Fluoreszenz tienscher Gewebe in ultraviolettem 
Licht. Pfluegers Arch 142:1-14, 1911 
July 1973 
37. T reff W M: Das Involu t ionsmuster des N ucleus dentatus cerebell i, 
Altern. Edi ted by 0 P latt. Stu ttga rt, Schattauer, 1974 
38. Bra ndes D, GYOl·key F, Groth D: Fine structure a nd his tochemical 
study of t he effect of castra tion on the rat prostate complex. Lab 
Invest 11:339-350, 1962 
39. J ohnson R, Strehler B: Loss of genes coding fo r ribosomal RNA in 
aging bra in ce lls. Nature 240:4 12-4 14, 1972 
40. J ohnson R, Chrisp C, Strehler B: Selective loss of ribosomal R NA 
genes during t he aging of post-mitotic tissues. Mech Ageing Dev 
1:183-1 98, 1972 
AG IN G R ESEAR CH: CU RRE NT AND FUTU R E 7 
41. Johnson LK, Johnson RW, Strehler B: Card iac hypertrophy, aging 
and changes in cardiac ri bosoma l RN A gene dosage in ma n. J 
Mol Cell Cardiol 7: 125-133, 1975 
42. Strehle r BL: Roles and mecha nisms of rONA changes du ring aging. 
B irt h Defects: Origina l Article Series of T he Na t iona l Foundation 
14(1):449-462, 1978 
43. Ma nn OMA, Yates PO: Lipoprotein pigments-their re lationship 
to ag ing in the human nervous system.!. T he lipofuscin content 
of ne rve ce lls. II . T he mela nin conten t of pigment nerve ce lls. 
B ra in 97:48 1- 488, 489- 498, 1974 
Announcement 
The Society for Investigative Dermatology, Inc., Change of Office 
Address 
Beginning July 15, 1979, all co rrespondence relating to activities of the Society for Investigative 
Dermatology, Inc. should be sent to: Kirk D . Wuepper, M .D., Secretaj·y-Treasurer, The Society for 
Investigative D ermatology, Inc., 14435 S. W. Uplands Drive, Lake Oswego, Oregon 97034. 
